Results

Total Results: 1,684 records

Showing results for "prostate cancer screening".
Users also searched for: psa

1341. Nrd 2011 Maskedstats Core V2 Weighted (pdf file)
      hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_Core_V2_Weighted.PDF
      January 01, 2011 - 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 3,426 0.01% 10: Immunizations and screening … DXCCS1 DXCCS1 Frequency Percent of Total 28: Cancer of other female genital organs 7,086 0.02% 29: Cancer … of prostate 96,993 0.26% 30: Cancer of testis 1,624 0.00% 31: Cancer of other male genital organs … 0.01% 256: Medical examination/evaluation 5,543 0.02% 257: Other aftercare 13,509 0.04% 258: Other screening … Substance-related disorders 230,113 0.62% 662: Suicide and intentional self-inflicted injury 2,457 0.01% 663: Screening

1342. Nrd 2010 Maskedstats Core V2 Weighted (pdf file)
      hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Core_V2_Weighted.PDF
      January 01, 2010 - 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 3,435 0.01% 10: Immunizations and screening … DXCCS1 DXCCS1 Frequency Percent of Total 28: Cancer of other female genital organs 6,812 0.02% 29: Cancer … of prostate 93,547 0.25% 30: Cancer of testis 1,733 0.00% 31: Cancer of other male genital organs … 0.00% 256: Medical examination/evaluation 6,594 0.02% 257: Other aftercare 13,310 0.04% 258: Other screening … Substance-related disorders 222,522 0.60% 662: Suicide and intentional self-inflicted injury 2,761 0.01% 663: Screening

1343. Periodic Issue | PSNet
      psnet.ahrq.gov/periodic-issue/periodic-issue-337
      April 27, 2022 - CDSS, researchers identified barriers (i.e., lack of patient-specific characteristics and DDI-specific screening … MD, MS | March 31, 2022 This Spotlight Case describes an older man incidentally diagnosed with prostate … cancer, with metastases to the bone.

1344. Maskedstats Nis 2015Q1Q3 Dx Pr Grps (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Dx_Pr_Grps.PDF
      November 08, 2017 - 2,503 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 551 0.01% 10: Immunizations and screening … DXCCS1 DXCCS1 Frequency Percent of Total 28: Cancer of other female genital organs 806 0.01% 29: Cancer … of prostate 10,276 0.19% 30: Cancer of testis 246 0.00% 31: Cancer of other male genital organs 131 … 0.01% 256: Medical examination/evaluation 627 0.01% 257: Other aftercare 3,442 0.06% 258: Other screening … Substance-related disorders 34,386 0.64% 662: Suicide and intentional self-inflicted injury 483 0.01% 663: Screening

1345. Maskedstats Nrd 2015Q1Q3 Dx Pr Grps (pdf file)
      hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Dx_Pr_Grps.PDF
      October 31, 2017 - 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 1,513 0.01% 10: Immunizations and screening … 0.03% 27: Cancer of ovary 9,545 0.07% 28: Cancer of other female genital organs 2,275 0.02% 29: Cancer … of prostate 28,763 0.22% 30: Cancer of testis 546 0.00% 31: Cancer of other male genital organs 366 … 0.01% 256: Medical examination/evaluation 1,022 0.01% 257: Other aftercare 5,802 0.04% 258: Other screening … Substance-related disorders 87,729 0.68% 662: Suicide and intentional self-inflicted injury 985 0.01% 663: Screening

1346. Nrd 2014 Maskedstats Core Weighted (pdf file)
      hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Core_Weighted.PDF
      January 01, 2014 - 0.05% 9: Sexually transmitted infections (not HIV or hepatitis) 3,788 0.01% 10: Immunizations and screening … DXCCS1 DXCCS1 Frequency Percent of Total 28: Cancer of other female genital organs 5,925 0.02% 29: Cancer … of prostate 68,063 0.19% 30: Cancer of testis 1,585 0.00% 31: Cancer of other male genital organs … 0.01% 256: Medical examination/evaluation 3,484 0.01% 257: Other aftercare 15,571 0.04% 258: Other screening … Substance-related disorders 229,084 0.65% 662: Suicide and intentional self-inflicted injury 2,430 0.01% 663: Screening

1347. Probability and the Diagnostic Pathway | Agency for Healthcare Research and Quality
      ce.effectivehealthcare.ahrq.gov/diagnostic-safety/resources/issue-briefs/probabilistic-thinking3.html
      September 01, 2022 - few clinicians currently conceptualize tests through a lens of benefits and harms, the approach to screening … we can frame decisions around PSA tests as a balance between potential benefits (e.g., reduction in prostate … cancer deaths or advanced disease) and harms (e.g., urinary incontinence and erectile dysfunction).

1348. References
      cmext.ahrq.gov/confluence/pages/viewinfo.action?pageId=114990878
      September 22, 2021 - q=prostate+cancer+screening     https://www.ahrq.gov/hai

1349. References
      cmext.ahrq.gov/confluence/pages/viewinfo.action?pageId=114991794
      September 22, 2021 - q=prostate+cancer+screening     https://www.ahrq.gov/hai

1350. References
      cmext.ahrq.gov/confluence/pages/viewinfo.action?pageId=114991682
      September 22, 2021 - q=prostate+cancer+screening     https://www.ahrq.gov/hai

1351. References
      cmext.ahrq.gov/confluence/pages/viewinfo.action?pageId=114991660
      September 22, 2021 - q=prostate+cancer+screening     https://www.ahrq.gov/hai

1352. Nis 2007 Maskedstats Core Weighted (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2007_MaskedStats_Core_Weighted.PDF
      January 01, 2007 - 19089 0.05 9: Sexually transmitted infections (not HIV or hepatitis) 4788 0.01 10: Immunizations and screening … DXCCS1 DXCCS1 Frequency Percent of Total 28: Cancer of other female genital organs 7033 0.02 29: Cancer … of prostate 102346 0.26 30: Cancer of testis 2036 0.01 31: Cancer of other male genital organs 971 … 2411 0.01 256: Medical examination/evaluation 12119 0.03 257: Other aftercare 35224 0.09 258: Other screening … Substance-related disorders 228887 0.58 662: Suicide and intentional self-inflicted injury 396 0.00 663: Screening

1353. Disposition of Comments for CER 153 Non-Muscle-Invasive Bladder Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
      October 27, 2015 - accurate are urinary biomarkers in detecting urothelial cancer in the previously undiagnosed patient/screening … --how often and how long should cytology be performed in evaluation and followup of screening patient … As noted in the methods, we excluded studies of biomarkers for screening (i.e. for diagnosis of bladder … product in the final report, I understand it may also outperform all others in respect to haematuria screening

1354. Disposition of Comments for CER 153 Non-Muscle-Invasive Bladder Cancer (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
      October 27, 2015 - accurate are urinary biomarkers in detecting urothelial cancer in the previously undiagnosed patient/screening … --how often and how long should cytology be performed in evaluation and followup of screening patient … As noted in the methods, we excluded studies of biomarkers for screening (i.e. for diagnosis of bladder … product in the final report, I understand it may also outperform all others in respect to haematuria screening

1355. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/whbbEX529Ha4FyvsYv6uh6
      April 26, 2022 - risk factors such as family history of CRC were not reported in any RCT, and only 1 RCT73 reported CRC screening … rates (51.4% in the aspirin group and 52.4% in the placebo group self-reported receiving a screening … Further, these ef- fects were not adjusted for CRC screening or risk factors. … would be ideal to examine the marginal effects of aspirin use in the context of con- temporary CRC screening … ACG clinical guidelines: colorectal cancer screening 2021.

1356. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/2GDCmTe7akyrAHsTMbfz72
      May 06, 2022 - risk factors such as family history of CRC were not reported in any RCT, and only 1 RCT73 reported CRC screening … rates (51.4% in the aspirin group and 52.4% in the placebo group self-reported receiving a screening … Further, these ef- fects were not adjusted for CRC screening or risk factors. … would be ideal to examine the marginal effects of aspirin use in the context of con- temporary CRC screening … ACG clinical guidelines: colorectal cancer screening 2021.

1357. Microsoft Word - 2011_04.docx (pdf file)
      hcup-us.ahrq.gov/reports/methods/2011_04.pdf
      January 01, 2011 - transmitted infections (not HIV or hepatitis) 10 84445 1.18135 1.19507 0.98852 Immunizations and screening … 4131 1.16409 1.21149 0.96088 Cancer of other female genital organs 29 60309 1.07459 1.13293 0.9485 Cancer … of prostate 30 84445 1.18135 1.19507 0.98852 Cancer of testis 31 84445 1.18135 1.19507 0.98852 Cancer … evaluation 257 15081 1.2269 1.19619 1.02567 Other aftercare 258 84445 1.18135 1.19507 0.98852 Other screening … 1.19507 0.98852 Suicide and intentional self-inflicted injury 663 46131 1.22048 1.29491 0.94252 Screening

1358. Minimal Modeling Approaches to Value of Information Analysis for Health Research (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
      June 01, 2011 - search produced 230 hits, while 120 studies were identified as potentially relevant following the screening … prednisone alone in patients with hormone- resistant prostate cancer Ramipril (ACE inhibitor) … Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate … cancer: a Canadian trial with palliative endpoints. … cancer: based on a Canadian trial with palliative endpoints.

1359. Minimal Modeling Approaches to Value of Information Analysis for Health Research (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
      June 01, 2011 - search produced 230 hits, while 120 studies were identified as potentially relevant following the screening … prednisone alone in patients with hormone- resistant prostate cancer Ramipril (ACE inhibitor) … Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate … cancer: a Canadian trial with palliative endpoints. … cancer: based on a Canadian trial with palliative endpoints.

1360. G:CIRD565TQMothers able1.PDF (pdf file)
      hcup-us.ahrq.gov/reports/natstats/his96/table1.pdf
      February 11, 2011 - 16,998 0.05 $11,650 $3,800 $6,591 $12,197 5.8 2.0 47.8 45.1 1.5 Immunizations and screening … genital organs 109,794 0.31 $11,724 $6,553 $9,940 $14,456 4.3 1.6 100.0 67.0 2.8.1 Cancer … of prostate [29.] 107,106 0.31 $11,646 $6,576 $9,929 $14,400 4.3 1.6 100.0 67.7 … $9,656 $3,077 $5,400 $10,025 9.6 0.1 40.1 30.2 5.10 Personal history of mental disorder, screening … ] 74,484 0.21 $9,650 $3,146 $6,027 $11,197 9.0 4.1 37.8 65.1 17.2.5 Other screening